Stocks / NKTR
Stock profile · 銘柄

Nektar Therapeutics - Common Stock (NKTR)

NKTR did not make Shishin's board on 2026-07-14: not in a strong uptrend (60-day return under 30%, or below its 50-day average). This is a mechanical screen result, not a view on the company. The figures below are research data, the mechanical screen result and the momentum, trend, and volatility indicators the engines observe, not investment advice.

Shishin's live daily signals are published each morning on the rankings board.

Shishin Score20
In today's boardNo
SetupOTHER
Last close$68.32
SectorBiotechnology
Today's scan · 2026-07-14
Not screenedComposite 20/100

NKTR did not make Shishin's board on 2026-07-14: not in a strong uptrend (60-day return under 30%, or below its 50-day average). This is a mechanical screen result, not a view on the company.

Position
33
Thrust
29
Breakout
20
Base
38
Volatility
54
Liquidity
50
Indicators · as of 2026-07-14
ADR · 20d5.8%
ATR · 145.9%
RSI · 1451
Return · 30d+5%
Return · 60d-18%
Above MA203%
Above MA50-0%
Range · 20d31%
MA stack1
From 52w high-37%
$ Vol · 30d$41M
Vol ratio0.62×
Frequently asked

Is NKTR a Shishin signal?

On 2026-07-14, NKTR is not in Shishin's board. Not in a strong uptrend (60-day return under 30%, or below its 50-day average). This is a mechanical screen result, not a recommendation.

What is NKTR's Shishin momentum score?

As of 2026-07-14, NKTR's composite momentum score is 20/100, a weighted blend of momentum, trend, and volatility indicators on a 0 to 100 scale.

Why didn't NKTR make the board?

Not in a strong uptrend (60-day return under 30%, or below its 50-day average). Shishin's board takes only the names that clear its liquidity, trend, and score thresholds for the active market regime.

Research data, not investment advice. Shishin publishes what its systematic engines observe; it does not recommend buying or selling any security, and is not a registered investment adviser or broker-dealer. See our risk disclosure.

Today's full rankings →Rate your watchlist →All covered stocks →